LLY 주가 차트
LLY 재무
Eli Lilly and Co
$967.08
1.96%
$18.62
종가: May 11, 16:00:00 GMT-4
$965.5
-0.16%
$-1.58
애프터마켓: May 11, 17:57:59 GMT-4
뒤로
Eli Lilly and Co (LLY) 재무
주요 통계
이전 종가
$948.45
시가
$947.67
일일 범위
$943.26 - $995
52주 범위
$623.78 - $1,133.95
거래량
2.4M
평균 거래량
3.0M
배당수익률
0.60%
EPS(TTM)
28.15
시가총액
$912.2B
LLY란 무엇인가요?
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees. The firm manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.
